Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer immunotherapies more effective.
Aug 4, 2026
0
197
Teeth and bones are among the hardest structures in the human body, but certain inherited conditions can rob them of that strength. One of them is hypophosphatasia (HPP), a rare, lifelong genetic bone disorder that disrupts ...
Since its discovery in Japan in 2009, a deadly fungus has emerged in hospitals around the world. The pathogen, known as Candida auris, lives silently on the skin. But it can be deadly if it reaches the bloodstream, killing ...
Aug 6, 2026
0
150
Hair loss is often caused by a combination of heredity and aging, says Dr. Dawn Davis, a Mayo Clinic dermatologist. Treatments that may slow that type of hair loss and help regrow hair, including over-the-counter therapies ...
Aug 7, 2026
0
148
Whether you are first-born or second-born may be associated with your risk of developing certain diseases, according to a new study published in Nature Health.
Parkinson's disease affects more than 10 million people worldwide. The disease is characterized by the buildup of abnormal clumps of the protein alpha-synuclein inside brain cells, but scientists have long struggled to understand ...
Aug 7, 2026
0
130
Seeing feels immediate; we open our eyes and the world seems to appear as a continuous stream. But some visual illusions show that events occurring later can change how we perceive what happened earlier, suggesting that the ...
Aug 7, 2026
0
126
A massive analysis of immune cells in human tissue is yielding clues to the root causes of lung and autoimmune diseases.
Aug 4, 2026
0
119
A protein named tau, which has been strongly implicated in the world's No. 1 cause of dementia—Alzheimer's disease—and several other neurodegenerative disorders, may spur these diseases in a way that differs greatly from ...
Aug 6, 2026
0
117
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a Phase III clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, ...
Aug 7, 2026
0
114
